How Big is the Oncology Market | Manufacturers 2025

What is the size of Oncology Market?

The market continues to grow consistently as improvements in patient outcomes occur due to advancements in precision medicine, targeted therapies, and early detection methods while the rising investments into research continue to solidify new cancer treatment choices across a range of oncology segments around the globe.

Growth Factors for Oncology Industry

• Growing incidence of cancer among different demographics leading to higher treatment demands.
• Increased investment in sophisticated diagnostics and molecular profiling.
• More immuno-oncology therapies leading to increased patient survival rates.
• Increase in clinical trials for novel targeted and combination therapies.
• Increased use of AI-assisted instruments for oncology research and personalized treatment.

Oncology Market Trends

Oncology market trends reflect a profound shift toward personalized treatment journeys, with precision medicine and biomarker-driven therapies on the rise. Immuno-oncology will continue to be a major market mover, backed by emerging imaging technologies, advanced less invasive diagnostics for early detection and monitoring.

Oncology market trends have also taken off with outpatient cancer care, propelled by more efficient and affordable treatment pathways and drug delivery methods. New oral oncology medications are being developed by pharmaceutical companies, and digital health platforms are improving patient adherence and real-time tracking of patient outcomes. 

Emerging Developments in the Oncology Market

The oncology market developments indicate a growing development towards adaptive clinical trial designs, allowing faster evaluation of new promising therapies. Companies are adopting genomic sequencing as an integral part of standard operating procedures to direct treatment and improve outcomes, including timing or duration of interventions. 

In addition, biotech companies establishing partnerships with academic institutions to speed up their innovation pipelines, are noteworthy developments in oncology. 

Oncology market developments are also facilitating tele-oncology services for specialist consultations and improved cancer access. The emergence of next-generation sequencing kits, companion diagnostics and liquid biopsy are changing how we detect and treat cancer.

List of Leading Companies in the Oncology Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Roche Holding AG

Roche is a global leader in oncology, offering innovative cancer diagnostics and targeted therapies for breast, lung, blood, and gastrointestinal cancers.

2. Novartis AG

Novartis develops and markets a broad oncology portfolio, including targeted therapies, immuno-oncology drugs, and cell and gene therapies for multiple cancer indications.

3. Bristol Myers Squibb Company

Bristol Myers Squibb specializes in oncology treatments, focusing on immunotherapies and targeted drugs to address hematologic malignancies and solid tumors.

4. Pfizer Inc.

Pfizer develops innovative oncology drugs, combining targeted therapies and immuno-oncology approaches to improve survival and quality of life for cancer patients.

5. Merck & Co., Inc.

Merck leads in immuno-oncology, notably with its PD-1 inhibitor Keytruda, addressing a wide range of cancers through precision medicine and research.

6. AstraZeneca plc

AstraZeneca focuses on targeted oncology therapies, immuno-oncology agents, and combination treatments for lung, ovarian, breast, and blood cancers.

7. Eli Lilly and Company

Eli Lilly develops oncology medicines for breast, lung, and blood cancers, emphasizing targeted therapies, immunotherapies, and biomarker-driven treatment strategies.

8. Amgen Inc.

Amgen advances oncology through biologics and targeted treatments, addressing hematologic malignancies, solid tumors, and supportive cancer care needs.

9. Johnson & Johnson (Janssen Pharmaceuticals)

Janssen develops innovative oncology medicines for prostate, hematologic, and lung cancers, with a strong focus on immunotherapy and precision medicine.

10. Gilead Sciences, Inc.

Gilead focuses on oncology through targeted small molecules and cell therapies, addressing blood cancers and expanding into solid tumor treatment.

How Big is the Oncology Market 2025: FAQs